In vitro anaphylaxis in guinea-pig skin: amplification by burimamide.
The effects of burimamide, an H2-antihistamine, on the anaphylactic reaction in the skin of ovalbumin-sensitized guinea pigs were studied in vitro. Burimamide enhanced the concentration of histamine in the supernatant fraction of antigen-challenged sensitized guinea-pig skin in a dose-related way, but did not alter the concentration of residual histamine in the skin after antigen challenge. The enhanced histamine concentration in the supernatant was not due to increased histamine synthesis by the target cells during the reaction because the increase was not inhibited by a histidine decarboxylase inhibitor, Brocresine. In further experiments it was shown that guinea-pig skin possesses potent histamine degrading enzyme activity which is inhibited by burimamide. We suggest that inhibition of these degrading enzymes leads to the increase in histamine concentration in the presence of burimamide.
D000707:Anaphylaxis / Q000201:enzymology / Q000378:metabolism*; D000818:Animals; D001958:Brocresine / Q000494:pharmacology; D002049:Burimamide / Q000378:metabolism / Q000494:pharmacology*; D006168:Guinea Pigs; D006632:Histamine / Q000378:metabolism; D006640:Histidine Decarboxylase / Q000037:antagonists & inhibitors; D066298:In Vitro Techniques; D008297:Male; D012867:Skin / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism; D013890:Thiourea / Q000031:analogs & derivatives*
D001958:Brocresine; D006632:Histamine; D006640:Histidine Decarboxylase; D013890:Thiourea; D002049:Burimamide